Sort
39,280 grants matching “leukemia”
Center for Gene Therapy of Cystic Fibrosis
$1,143,750John F Engelhardt · University Of Iowa · P30 · FY2017 · DK
DEVELOPMENTAL FUNDS (Core 002)
$1,142,799Michael A Caligiuri · Ohio State University · P30 · FY2020 · CA
Studies of Host Cellular Proteins Required for viral Budding and release
$1,142,704Fadila Bouamr · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Center for Gene Therapy of Cystic Fibrosis
$1,142,254John F Engelhardt · University Of Iowa · P30 · FY2019 · DK
Myelodysplasia
$1,142,177Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Novel Biologic Therapies for GVHD
$1,141,368Leslie S Kean · Boston Children'S Hospital · R01 · FY2025 · HL
Center for Gene Therapy of Cystic Fibrosis
$1,140,938John F Engelhardt · University Of Iowa · P30 · FY2016 · DK
Mechanisms of axon guidance during development
$1,140,478Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Lymphoma Disease Discovery and Defintion
$1,139,894Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing
$1,139,103Kellie Bickel · Twinstrand Biosciences, Inc. · R44 · FY2023 · CA
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
$1,138,913Matthew Reed · Nob Hill Therapeutics, Inc. · R44 · FY2025 · CA
Biomedical Simulations Resource (BMSR)
$1,138,362David Z D'argenio · University Of Southern California · P41 · FY2011 · EB
Apoptosis-Based Cancer Drug Discovery
$1,137,818John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U19 · FY2007 · CA
Experimental Therapeutics of Pediatric Hematopoietic Malignancies
$1,135,420Alan S Wayne · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Experimental Therapeutics of Pediatric Hematopoietic Malignancies
$1,134,017Alan S Wayne · Division Of Clinical Sciences - Nci · ZIC · FY2010 · CA
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$1,133,603Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Myelodysplasia
$1,132,969Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Center for Gene Therapy of Cystic Fibrosis
$1,132,500John F Engelhardt · University Of Iowa · P30 · FY2015 · DK
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$1,132,346Sung-Yun Pai · Boston Children'S Hospital · U01 · FY2016 · AI
MolecularCellular Regulation of Hematopoiesis
$1,132,187Jonathan R Keller · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Nuclear Structure and Gene Expression
$1,132,152Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2014 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,131,849Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Tolerance In Organ Transplantation And Autoimmune Disease By T Cell Immunotoxin
$1,131,747David M. Neville · National Institute Of Mental Health · Z01 · FY2007 · MH
Viral And Cellular Factors Governing Efficient Gene Delivery
$1,131,747Maribeth V. Eiden · National Institute Of Mental Health · Z01 · FY2007 · MH
Bio-Therapies for the Treatment of Cancer and Infectious Disease
$1,131,591David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA